First-in-Human trial launches for marburg virus vaccine
⭐️ VACCINE ⭐️
Completed
This early-stage study tested a new vaccine (PHV01) against Marburg virus, a rare but deadly disease. Thirty-six healthy adults received either the vaccine or a placebo to check for side effects and see if the vaccine triggers an immune response. The study is complete and followe…
Phase: PHASE1 • Sponsor: Public Health Vaccines LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 03, 2026 12:02 UTC